ALX Oncology Holdings Inc. Common Stock ALXO
i
Market datapartial · fetched 2026-11-13T19:10:53.147Z
Delta surfaceAlpaca · derived absolute-delta buckets · 2027-01-15
Calculation methodologyOptions historyIV: ThetaData historical Greeks, equal-weight mean of call/put 50-delta IV across the next four listed Friday-cycle expirations, including holiday shifts verified against ThetaData’s market calendar. Missing inputs leave gaps. Skew: equal-weight mean of put minus call IV across those four expirations. IV-implied move history: mean of each expiration’s average call/put IV multiplied by the square root of remaining calendar days divided by 365.25; percentage of spot, not a quoted straddle premium.
History dataPriceAlpaca · sip · 2026-11-13T19:10:39.163769852Z
FundamentalsAlpha Vantage · unavailable
ALX Oncology Holdings Inc. Common Stock options
Table
| Delta | Calls | Puts | ||||
|---|---|---|---|---|---|---|
| Pseudo strike | IV | B/E move | Pseudo strike | IV | B/E move | |
| 20Δ | ||||||
| 25Δ | 1.06 | 357.4% | 52.5% | |||
| 30Δ | 1.16 | 337.7% | 47.8% | |||
| 35Δ | 1.26 | 317.9% | 43.1% | |||
| 40Δ | 1.35 | 298.2% | 38.4% | |||
| 45Δ | 1.45 | 278.4% | 33.7% | |||
| 50Δ | 1.54 | 258.7% | 28.9% | |||
| 55Δ | 1.64 | 238.9% | 24.2% | |||
| 60Δ | 1.73 | 219.2% | 19.5% | |||
| 65Δ | 1.83 | 199.4% | 14.8% | |||
| 70Δ | 1.93 | 179.7% | 10.1% | |||
| 75Δ | 2.18 | 168.8% | 6.0% | |||
| 80Δ | 3.01 | 189.7% | 3.9% | |||
20Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
25Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 1.06
- IV
- 357.4%
- B/E move
- 52.5%
30Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 1.16
- IV
- 337.7%
- B/E move
- 47.8%
35Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 1.26
- IV
- 317.9%
- B/E move
- 43.1%
40Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 1.35
- IV
- 298.2%
- B/E move
- 38.4%
45Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 1.45
- IV
- 278.4%
- B/E move
- 33.7%
50Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 1.54
- IV
- 258.7%
- B/E move
- 28.9%
55Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 1.64
- IV
- 238.9%
- B/E move
- 24.2%
60Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 1.73
- IV
- 219.2%
- B/E move
- 19.5%
65Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 1.83
- IV
- 199.4%
- B/E move
- 14.8%
70Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 1.93
- IV
- 179.7%
- B/E move
- 10.1%
75Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 2.18
- IV
- 168.8%
- B/E move
- 6.0%
80Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 3.01
- IV
- 189.7%
- B/E move
- 3.9%
Options history
Table
| Date | IV (%) |
|---|---|
| 193.01% | |
| 207.30% | |
| 260.88% | |
| 189.86% | |
| 223.08% | |
| 179.21% | |
| 201.47% | |
| 169.41% | |
| 158.11% | |
| 222.94% | |
| 225.18% | |
| 215.26% | |
| 218.18% | |
| 244.16% | |
| 276.26% | |
| 283.90% | |
| 247.65% | |
| 247.49% | |
| 238.45% | |
| 293.44% | |
| 301.90% | |
| 324.61% | |
| 282.42% | |
| 287.46% |
Biotechnology
ANAB
Description unavailable
More →ANIX
Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines focusing on critical unmet needs in oncology and infectious diseases. The company is…
More →ANNX
Description unavailable
More →ANRO
Alto Neuroscience, Inc. is a clinical-stage biopharmaceutical company that engages in the psychiatry drug development business. The company is headquartered in Los Altos,…
More →ANTX
Description unavailable
More →ARCT
Description unavailable
More →